FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+20.19%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$169M
AUM Growth
+$169M
(+20%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
11.47%
Top 10 Holdings %
Top 10 Hldgs %
87.24%
Holding
22
New
3
Increased
5
Reduced
6
Closed
6
Top Buys
1 |
Larimar Therapeutics
LRMR
|
$48.4M |
2 |
EPZM
Epizyme, Inc
EPZM
|
$10.4M |
3 |
RGLS
Regulus Therapeutics
RGLS
|
$7.28M |
4 |
NVET
Nexvet Biopharma plc Ordinary Shares
NVET
|
$5.69M |
5 |
Sangamo Therapeutics
SGMO
|
$2.59M |
Top Sells
1 |
UAM
Universal American Corp
UAM
|
$27.8M |
2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$9.71M |
3 |
SAGE
Sage Therapeutics
SAGE
|
$5.29M |
4 |
ProQR Therapeutics
PRQR
|
$3.75M |
5 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$3.45M |
Sector Composition
1 | Healthcare | 83.69% |